Kendra Goldhirsch is an Associate at the Firm. Ms. Goldhirsch is a 2015 New York Metro Super Lawyers Rising Star. Her practice focuses on national product liability litigation and mass torts.
The FDA released another safety warning concerning type 2 diabetes medication Invokana (canagliflozin). Back in May 2015, the administration warned doctors and patients of the potential for Invokana to increase risk of diabetic ketoacidosis (DKA), a condition in which the blood becomes too acidic. W
Health Canada has completed a safety review of Xarelto (rivaroxaban), a newer-generation anti-coagulant medication manufactured by Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson). According to a Summary Safety Review released on August 26, 2015, the department investigated the medication
In June 2015, researchers published a new study on Cook IVC filters. They compared the Cook Celect with the Option filters, and reported the results. Those results raised concerns in the medical community that certain IVC filters, which are used to help prevent pulmonary embolism…